Vizdrot MF 80mg/250mg Tablet
Marketer
Viziott Pharmaceuticals
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Vizdrot MF 80mg/250mg Tablet
Abdominal pain is treated with the combined medication, Vizdrot MF 80mg/250mg Tablet. This medication effectively alleviates abdominal pain, bloating, discomfort, and cramping by relaxing the stomach and intestinal muscles. It also inhibits pain-inducing chemical signals. Vizdrot MF 80mg/250mg Tablets should be taken with food, following your doctor's prescribed dosage and duration. Your individual dosage will depend on your condition and response. Continue taking this medication as directed; premature discontinuation may cause symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Common side effects, such as diarrhea, nausea, vomiting, stomach pain, dry mouth, appetite loss, thirst, and heartburn, are generally temporary and self-limiting. However, report any concerning side effects immediately. Dizziness and drowsiness are also potential effects; refrain from driving or activities requiring concentration until the effects are known. Alcohol consumption should be avoided due to potential increased dizziness. Inform your doctor of pregnancy, pregnancy planning, breastfeeding, or kidney/liver disease prior to commencing treatment to ensure appropriate dosage.
Primary Ingredients of Vizdrot MF 80mg/250mg Tablet
No text provided to rephrase.
Uses of Vizdrot MF 80mg/250mg Tablet
Managing discomfort in the abdomen
Major Benefits of Vizdrot MF 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 80mg/250mg Vizdrot MF tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Vizdrot MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Vizdrot MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Vizdrot MF 80mg/250mg tablets should be administered with a meal.
How Vizdrot MF 80mg/250mg Tablet works:
Vizdrot MF 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain- and inflammation-inducing chemicals, reducing both discomfort and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vizdrot MF 80mg/250mg Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Vizdrot MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Vizdrot MF 80mg/250mg Tablet while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Vizdrot MF 80mg/250mg tablets might lead to adverse reactions, potentially impairing driving ability due to the possibility of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Vizdrot MF 80mg/250mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Vizdrot MF 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Vizdrot MF 80mg/250mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Vizdrot MF 80mg/250mg Tablet :
Should you forget a Vizdrot MF 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vizdrot MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently